Enanta Pharmaceuticals Inc (ENTA) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $14.41
• Market Cap: $424.84M
• EPS: $-3.21
• 52-Week High: $17.15
• 52-Week Low: $4.09

Market Sentiment

Enanta Pharmaceuticals Inc currently has a Bearish sentiment score of -0.30.

About Enanta Pharmaceuticals Inc

Enanta Pharmaceuticals, Inc., located in Watertown, Massachusetts, is a biotechnology firm dedicated to the discovery and development of groundbreaking small molecule therapeutics aimed at combating viral infections and liver diseases. The company boasts a robust pipeline that includes candidates specifically targeting hepatitis B and other viral pathogens, underscoring its extensive scientific expertise and innovative drug development capabilities. With a strategic focus on advancing its pro...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Enanta Pharmaceuticals Inc and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does ENTA pay dividends?

Enanta Pharmaceuticals Inc (ENTA) does not currently pay a regular dividend.

What is ENTA's market cap?

Enanta Pharmaceuticals Inc (ENTA) has a market capitalization of $424.84M with a current stock price of $14.41.